Search results for "Cholesterol"


 
Results 31 - 40 of about 415 for "Cholesterol".
Sort by: Relevance | Newest | Oldest

Shared physician and patient financial incentives associated with most LDL improvement

Participants were randomized to 1 of 4 groups: a control group, a group where physicians could receive up to $1,024 per patient meeting LDL goals, a group where patients could win up to $1,024 in daily lotteries for medication adherence, or a group where the incentives were shared between physicians and patients.
https://immattersacp.org/weekly/archives/2015/11/17/6.htm
17 Nov 2015

Some traditional Chinese medicine may provide benefits in cardiovascular conditions

Some traditional Chinese medications might be used as a complementary and alternative approach for primary and secondary prevention of cardiovascular disease, but further long-term study is needed.
https://immattersacp.org/weekly/archives/2017/06/13/2.htm
13 Jun 2017

The never-ending push-pull of statins

Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017

Overcoming care barriers for transgender patients

Negative experiences for transgender patients can be avoided through gender-affirming care by physicians.
https://immattersacp.org/archives/2023/01/overcoming-care-barriers-for-transgender-patients.htm
1 Jan 2023

Aspirin associated with fewer CV events, more major bleeding in healthy patients, review finds

When weighing the risks and benefits of aspirin for primary cardiovascular (CV) prevention in individual patients, clinicians must also consider other interventions that may lower risk, an accompanying editorial said.
https://immattersacp.org/weekly/archives/2019/01/29/1.htm
29 Jan 2019

PCSK9 inhibitor appears more effective than ezetimibe for short-term LDL lowering in small, randomized trial

The authors of an accompanying editorial noted that PCSK9 inhibitors like evolocumab are not approved for the indication in the trial and have not yet been shown to reduce cardiovascular events.
https://immattersacp.org/weekly/archives/2016/04/05/5.htm
5 Apr 2016

Taking a weight off diabetes care

Not only is the focus on weight not beneficial to diabetes patients, it can cause other health consequences such as weight cycling and eating disorders.
https://immattersacp.org/archives/2020/09/taking-a-weight-off-diabetes-care.htm
1 Sep 2020

Stopping preventive aspirin associated with 37% increased risk of cardiovascular events

Patients who continued aspirin had a 4.1% yearly incidence of cardiovascular events, compared to 5.4% among those who stopped taking the drug, while the risk of discontinuation corresponded to one additional cardiovascular event for every 74 patients who stopped taking aspirin in a year.
https://immattersacp.org/weekly/archives/2017/10/03/4.htm
3 Oct 2017

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/11/latest-updates-on-acps-priorities-initiatives.htm
1 Nov 2022

MKSAP Quiz: Evaluation of risk for cardiovascular disease

A 49-year-old man is evaluated during a routine examination. He is asymptomatic but is concerned about his risk for cardiovascular disease. Medical history is notable for hypertension. He is a nonsmoker, and he works as an executive at a highly successful company. Family history is noncontributory. His only medication is hydrochlorothiazide. Following a physical exam and cholesterol and glucose testing, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/02/09/3.htm
9 Feb 2016

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next